De Novo Pharmaceuticals Ltd Company Profile

19:46 EDT 19th March 2018 | BioPortfolio

The volume of structural protein data that will emerge in the next few years will serve as a driver that transforms the pharmaceutical industry. Over the next decade it is predicted that the high-resolution 3-D structure of all proteins that precisely define the biological space of human, pathogenic organisms and plant proteomes will be available. As this flood of data on proteins becomes available, De Novo is centrally positioned to efficiently link biological space to chemical space.


Compass HouseVision ParkHiston
United Kingdom


Phone: 44 (0)1223 238000

News Articles [977 Associated News Articles listed on BioPortfolio]

Novo Nordisk: Passende Übernahme

Die Analysten der UBS bestätigen die Kaufempfehlung für die Aktien von Novo Nordisk aus Dänemark. Das Kursziel für die Papiere von Novo Nordisk sehen die Experten weiter bei 370,00 DKK. Die Dänen...

Ablynx Rejects Novo Nordisk’s $3.1 Billion Acquisition Proposal

GHENT, Belgium, 8 January 2018 – Ablynx NV (Euronext Brussels and Nasdaq: ABLX) (“Ablynx” or the “Company”) today confirmed that on December 22, 2017 it received an unsolicited condition...

Veloxis Pharmaceuticals Releases Annual Report for 2017

Highlights Veloxis Pharmaceuticals A/S agreed to amend and restate the terms of its previously announced loan and security agreement with Lundbeckfond Invest A/S and Novo Read more...

FDA Committee Votes 16-0 for Approval of Novo Nordisk Diabetes Treatment

NewsNovo Nordisk receives positive 16-0 vote from FDA advisory committee in favor of approval for semaglutide. The treatment is currently also under review by the European Medicines Agency and the Jap...

Ablynx’ Stock Jumps by 60% After Rejecting Acquisition from Novo Nordisk

Ablynx has rejected a generous acquisition offer from Novo Nordisk. As a result, its stock has soared and is now worth more than what Novo offered in the first place. Early this morning, Novo Nordisk...

Novo Holdings Pumps €135M into New Antibiotic Development to Fight Resistance

Novo Holdings has launched a $165M (€135M) impact fund to support companies that are developing new drugs to overcome antibiotic resistance. Novo Holdings is the venture capital arm of the Danish b...

Quotidian Technical Highlights on Selected Drug Makers Stocks -- Novo Nordisk, Sucampo Pharma, ... Novo Nordisk On Thursday, shares in Bagsvaerd, Denmarkheadquartered Novo Nordisk A/S recorded a trading volume of 2.22 million shares, which was above their R...

Sanofi outbids Novo with €45 per share offer for Ablynx, total of €3.8bn

Public Belgian biotech Ablynx NV agreed to be acquired by Sanofi, which offered €45 per share ($59.92; a 37% premium) for a fully diluted equity value of €3.8bn ($5.1bn). The deal trumps an offer ...

Drugs and Medications [296 Associated Drugs and Medications listed on BioPortfolio]

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

NOVOLIN N Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL

Pur-wash [Niagara Pharmaceuticals Inc.]


Myfortic [Novartis Pharmaceuticals Corporation]

Myfortic (mycophenolic   acid*) delayed-release tablets *as mycophenolate   sodium Rx only Prescribing Information

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

PubMed Articles [394 Associated PubMed Articles listed on BioPortfolio]

De Novo Synthesis of Benzannelated Heterocycles.

Benzannelated heterocycles such as indoles and indazoles are prominent structural motifs found in natural products, pharmaceuticals and agrochemicals. For their synthesis, chemists traditionally eithe...

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

The complete mitochondrial genome of the Dutch elm disease fungus Ophiostoma novo-ulmi subspecies novo-ulmi.

Ophiostoma novo-ulmi, a member of the Ophiostomatales (Ascomycota) is the causal agents of the current Dutch elm disease pandemic in Europe and North America. The complete mitochondrial genome (mtDNA)...

Clinical Trials [556 Associated Clinical Trials listed on BioPortfolio]

Evaluating Therapeutic Response to Novo-TTF

This study is to assess the utility of high resolution 3D echo planar magnetic resonance spectroscopy (3D EPSI) in monitoring Novo-TTF response in glioblastoma multiforme (GBM) patients.

De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions

The study will enroll patients with angiographically significant coronary de novo lesions. Subjects will be randomized 1:1 and treated with a Lutonix catheter either before or after bare-m...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1349 Associated Companies listed on BioPortfolio]

Novo A/S

Novo A/S is fully owned by the Novo Nordisk Foundation and is the holding company of the Novo Group. Novo A/S is a private limited liability company and the majority shareholder in the publicly listed...

Novo Nordisk A/S

Novo A/S, the holding company of the Novo Group, is fully owned by the Novo Nordisk Foundation and was established to manage the Foundation's funds and to invest actively in other companies. What make...

De Novo Pharmaceuticals

The commercial focus of De Novo is the exploitation of human genomics in drug discovery through in silico drug design. The company attracted £2 million financing in a first VC-backed investment roun...

Novo Nordisk, Inc.

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy...

NOVO Engineering

NOVO engineering ( is a leading privately held design engineering firm whose team of world-class engineers has been exceeding clients’ needs since 199...

More Information about "De Novo Pharmaceuticals Ltd" on BioPortfolio

We have published hundreds of De Novo Pharmaceuticals Ltd news stories on BioPortfolio along with dozens of De Novo Pharmaceuticals Ltd Clinical Trials and PubMed Articles about De Novo Pharmaceuticals Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of De Novo Pharmaceuticals Ltd Companies in our database. You can also find out about relevant De Novo Pharmaceuticals Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record